Stage A nonseminomatous testis carcinoma: rationale and results of nerve-sparing retroperitoneal lymphadenectomy.
The major objection to the use of retroperitoneal lymphadenectomy in low-stage testis cancer has been the universal loss of ejaculatory ability if a full bilateral dissection is performed. The Indiana University experience with nerve-sparing dissection is presented. One hundred percent of the patients subjected to this procedure maintain ejaculatory ability.
Foster
R S
RS
Department of Urology, Indiana University Medical Center, Indianapolis.
Donohue
J P
JP
Bihrle
R
R
D006801:Humans; D007431:Intraoperative Complications / Q000517:prevention & control*; D008197:Lymph Node Excision / Q000379:methods*; D008297:Male; D009367:Neoplasm Staging; D009373:Neoplasms, Germ Cell and Embryonal / Q000473:pathology / Q000601:surgery*; D009412:Nerve Fibers; D012187:Retroperitoneal Space; D013736:Testicular Neoplasms / Q000473:pathology / Q000601:surgery*